Evaluation of G2013 (α‐L‐guluronic acid) efficacy on PC‐3 cells through inhibiting the expression of inflammatory factors

Z Bagherian, A Mirshafiey… - Clinical and …, 2022 - Wiley Online Library
Given multiple treatment strategies for prostate cancer, its mortality rate is still high;
therefore, novel treatment strategies seem necessary. G2013 or α‐L‐guluronic acid is a new …
被引用次数：3 相关文章

Evaluation of G2013 (α-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors.

Z Bagherian, A Mirshafiey… - Clinical and …, 2021 - europepmc.org
Given multiple treatment strategies for prostate cancer, its mortality rate is still high;
therefore, novel treatment strategies seem necessary. G2013 or α-L-guluronic acid is a new …

Evaluation of G2013 (α-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors

Z Bagherian, A Mirshafiey… - Clinical and …, 2022 - pubmed.ncbi.nlm.nih.gov
Given multiple treatment strategies for prostate cancer, its mortality rate is still high;
therefore, novel treatment strategies seem necessary. G2013 or α-L-guluronic acid is a new …

Evaluation of G2013 (α‐L‐guluronic acid) efficacy on PC‐3 cells through inhibiting the expression of inflammatory factors.

Z Bagherian, A Mirshafiey… - Clinical & …, 2022 - search.ebscohost.com
Given multiple treatment strategies for prostate cancer, its mortality rate is still high;
therefore, novel treatment strategies seem necessary. G2013 or α‐L‐guluronic acid is a new …